🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, randomized, double-blind, placebo-controlled, parallel-...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01225393
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of PR...
Status
Completed
Location
Protalex Investigative Site
Start Date
2012-11
Trial ID
NCT01749787
The objective of the study is to establish a prospective disease registry f...
Status
Recruiting
Location
Seattle Children's Hospital
Start Date
2018-08-01
Trial ID
NCT04725422
This Phase 3, randomized, open-label, multicenter study in rheumatoid arthr...
Status
Terminated
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00521924
Systemic sclerosis (SSc) is an orphan, multiorgan disease affecting the con...
Status
Unknown
Location
University of Ghent, Department of Rheumatology
Start Date
2013-04
Trial ID
NCT01834157
Primary Objective: To assess, in the same study, the safety of sarilumab a...
Status
Completed
Location
Investigational Site Number 840152
Start Date
2013-03
Trial ID
NCT01768572
People with inflammatory diseases treated with immune-suppressing medicatio...
Status
Completed
Location
University of Nottingham
Start Date
2022-06-28
Trial ID
NCT05458531
Treatments Being Tested
This study aims to evaluate the effect of l-carnitine as add- on therapy fo...
Status
Recruiting
Location
Demerdash hospital
Start Date
2024-12-31
Trial ID
NCT06753565
Treatments Being Tested
A randomized controlled interventional study to evaluate the efficacy and s...
Status
Recruiting
Location
Ain Shams University Hospitals
Start Date
2023-12-02
Trial ID
NCT06640309
Treatments Being Tested
In the Care in Rheumatoid Arthritis (CareRA) trial (NCT01172639) about 70% ...
Status
Completed
Location
Imelda Ziekenhuis Bonheiden
Start Date
2018-06-08
Trial ID
NCT03649061
Treatments Being Tested